Subject characteristics, ECHO-SOL (n=1818)
| Variable | Total | Never | Former | Current |
| Age, years | 56.4±0.4 | 56.1 (0.5) | 58 (0.5) | 55 (0.6) |
| Female, % | 57.4 (1187) | 68.1(786) | 42.4(238) | 45.0 (163) |
| Body mass index, mean (kg/m2) | 30.1±0.2 | 30.6 (0.3) | 30.0 (0.3) | 29 (0.4) |
| Fasting glucose | 106±1.1 | 105 (1.4) | 109 (1.8) | 108 (2.3) |
| Heart rate (bpm) | 66±0.3 | 66 (0.4) | 65 (0.6) | 66 (0.7) |
| Hypertension, % | 50 (861) | 497 (49.4) | 227 (52.9) | 137 (47.9) |
| Systolic BP (mm Hg) | 136±0.6 | 137 (0.9) | 137 (1.2) | 134 (1.3) |
| Diastolic BP (mm Hg) | 78±0.4 | 78 (0.5) | 78 (0.7) | 78 (0.9) |
| Total cholesterol (mg/dL) | 209±1.4 | 210 (1.7) | 210 (3.3) | 201 (3.2) |
| Chronic kidney disease, % | 6.4 (106) | 6.7 (65) | 6.3 (24) | 5.8 (17) |
| Smoking status, % | 56.7 (1069) | 25.7 (443) | 17.6 (304) | |
| Current non-daily smokers | 19.1 (66) | |||
| Current daily smokers | 80.9 (238) | |||
| Diabetes status, % | ||||
| Non-diabetic | 29.5 (548) | 325 (29.7) | 133 (29.4) | 89 (29.1) |
| Prediabetic | 43.0 (747) | 448 (42.1) | 165 (39.7) | 133 (45.2) |
| Diabetic | 27.5 (523) | 296 (28.2) | 145 (30.9) | 82 (25.7) |
| Coronary heart disease, % | 6.9 (108) | 5.4 (54) | 9.9 (33) | 7.2 (21) |
| Heart failure, % | 3.6 (49) | 2.5 (26) | 5.7 (13) | 4.4 (10) |
| ACE inhibitors, % | 312 (17.1) | 191 (16.4) | 76 (18.9) | 45 (16.8) |
| Angiotensin receptor blockers, % | 140 (7.3) | 79 (7.1) | 50 (10.4) | 11 (3.6) |
| Beta blockers, % | 201 (12.1) | 114 (10.9) | 68 (18.2) | 19 (6.9) |
Data are presented as mean + SEM or % (unweighted N) using weighted row percentages. It is HCHS/SOL publication policy to present weighted percentages. Unweighted percentages can be calculated based on unweighted N’s listed. Chronic kidney disease defined by eGFR <60 ml/min.
BP, blood pressure; ECHO-SOL, Echocardiographic Study of Hispanics/Latinos; eGFR, estimated glomerular filtration rate; HCHS/SOL, Hispanic Community Health Study/Study of Latinos.